Drug therapy of post-stroke aphasia: A review of current evidence

Neuropsychology Review

Volumn 21, Issue 3, 2011, Pages 302-317

  Berthier, Marcelo L ^a   Pulvermüller, Friedemann ^b   Dávila, Guadalupe ^a   Casares, Natalia García ^a   Gutiérrez, Antonio ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

Author keywords

Aphasia recovery; Aphasia treatment; Pharmacological treatment; Stroke aphasia

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; MEMANTINE; NOOTROPIC AGENT;

APHASIA; BRAIN; DRUG EFFECT; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW; STROKE;

APHASIA; BRAIN; HUMANS; MEMANTINE; NEUROTRANSMITTER AGENTS; NOOTROPIC AGENTS; STROKE;

EID: 80755163637     PISSN: 10407308     EISSN: 15736660     Source Type: Journal    
DOI: 10.1007/s11065-011-9177-7     Document Type: Review

References (180)

1. Aarsland, D., Larsen, J. P., Reinvang, I., & Aasland, A. M. (1994). Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer type. Brain, 117, 1377-1384.
2. Albert, M. L., Bachman, D., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy of aphasia. Neurology, 38, 877-879.
3. Alexander, M. P. (2006). Impairments of procedures for implementing complex language are due to disruption of frontal attention processes. Journal of International Neuropsychological Society, 12, 236-247.
4. Altieri, M., Di Piero, V., & Lenzi, G. L. (2002). Drugs and recovery: A challenge for a few? Stroke, 33, 1170. letter.
5. Arciniegas, D. B., Frey, K. L., Anderson, C. A., Brousseau, K. M., & Harris, S. N. (2004). Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Injury, 18, 1309-1318. (Pubitemid 39496895)
6. Ashtary, F., Janghorbani, M., Chitsaz, A., Reisi, M., & Bahrami, A. (2006). A randomized, double blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology, 66, 914-916.
7. Auchus, A. P., Brashear, H. R., Salloway, S., Korczyn, A. D., De Deyn, P. P., Gassmann-Mayer, C., et al. (2007). Galantamine treatment of vascular dementia: A randomized trial. Neurology, 69, 448-458. (Pubitemid 47450280)
8. Baker, J. M., Rorden, C., & Fridriksson, J. (2010). Using transcranial direct-current stimulation to treat stroke patients with aphasia. Stroke, 41, 1129-1236.
9. Barker-Collo, S., & Feigin, V. (2006). The impact of neuropsychological deficits on functional stroke outcomes. Neuropsychology Review, 16, 53-64. (Pubitemid 44386777)
10. Barrett, A. M., & Eslinger, P. J. (2007). Amantadine for adynamic speech: Possible benefit for aphasia? American Journal of Physical Medicine and Rehabilitation, 86, 605-612. (Pubitemid 47220692)
11. Barrett, A. M., Levy, C. E., & Gonzalez Rothi, L. J. (2007). Pharmaceuticals for poststroke and brain injury rehabilitation. Americal Journal of Physical Medicine and Rehabilitation, 86, 603-604. (Pubitemid 47220691)
12. Basso, A. (2003). Aphasia and its therapy. Oxford: Oxford University Press.
13. Basso, A., & Caporali, A. (2001). Aphasia therapy or the importance of being earnest. Aphasiology, 15, 307-332. (Pubitemid 32293599)
14. Basso, A., & Macis, M. (2011). Therapy efficacy in chronic aphasia. Behavioural Neurology (in press).
15. Basso, A., Bracchi, M., Capitani, E., Laiacona, M., & Zanobio, M. E. (1987). Age and evolution of language area functions. A study on adult stroke patients. Cortex, 23, 475-483. (Pubitemid 17142362)
16. Bersano, A., Burgio, F., Gattinoni, M., Candelisem, L., & PROSIT Study Group. (2009). Aphasia burden to hospitalised acute stroke patients: Need for an early rehabilitation programme. International Journal of Stroke, 4, 443-447.
17. Berthier, M. L. (1999). Transcortical Aphasias. Hove: Psychology.
18. Berthier, M. L. (2005). Poststroke aphasia: Epidemiology, pathophysiology and treatment. Drugs & Aging, 22, 163-182. (Pubitemid 40445325)
19. Berthier, M. L., & Pulvermüller, F. (2011). Neuroscience insights improve neurorehabilitation of poststroke aphasia. Nature Reviews. Neurology, 7, 86-97.
20. Berthier, M. L., Hinojosa, J., Martín, M. C., & Fernandez, I. (2003). Open-label study of donepezil in chronic poststroke aphasia. Neurology, 60, 1218-1219. (Pubitemid 36418800)
21. Berthier, M. L., Moreno-Torres, I., & Hinojosa, J. (2004). Beneficial effects of donepezil and modalityspecific language therapy on chronic conduction aphasia. Neurology, 62(Suppl. 5), A462. abstract.
22. Berthier, M. L., Green, C., Higueras, C., Fernandez, I., Hinojosa, J., & Martín, M. C. (2006). A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology, 67, 1687-1689. (Pubitemid 44747948)
23. Berthier, M. L., Green, C., Lara, J. P., Higueras, C., Barbancho, M. A., Dávila, G., et al. (2009). Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Annals of Neurology, 65, 577-585.
24. Beversdorf, D. Q., Sharma, U. K., Phillips, N. N., Notestine, M. A., Slivka, A. P., Friedman, N. M., et al. (2007). Effect of propranolol on naming in chronic Broca's aphasia with anomia. Neurocase, 13, 256-259. (Pubitemid 350153955)
25. Bhogal, S. K., Teasell, R., & Speechley, M. (2003). Intensity of aphasia therapy, impact on recovery. Stroke, 34, 987-993.
26. Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G. L. (2000). Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurological Science, 21, 19-22. (Pubitemid 30430854)
27. Breier, J. I., Maher, L. M., Schmadeke, S., Hasan, K. M., & Papanicolaou, A. C. (2007). Changes in language-specific brain activation after therapy for aphasia using magnetoencephalography: A case study. Neurocase, 13, 169-177. (Pubitemid 47386776)
28. Breier, J. I., Juranek, J., Maher, L. M., Schmadeke, S., Men, D., & Papanicolaou, A. C. (2009). Behavioral and neurophysiologic response to therapy for chronic aphasia. Archives of Physical Medicine and Rehabilitation, 90, 2026-2033.
29. Cabeza, R. (2002). Hemispheric asymmetry reduction in older adults: The HAROLD model. Psychology and Aging, 17, 85-100. (Pubitemid 34241215)
30. Cappa, S. F., Benke, T., Clarke, S., Rossi, B., Stemmer, B., & van Heuten, C. M. (2003). EFNS guidelines on cognitive rehabilitation: Report of an EFNS Task Force. European Journal of Neurology, 10, 11-23. (Pubitemid 36114938)
31. Carter, A. R., Connor, L. T., & Dromerick, A. W. (2010). Rehabilitation after stroke: Current state of science. Current Neurology and Neuroscience Reports, 10, 158-166.
32. Chen, Y., Li, Y. S., Wang, Z. Y., Xu, Q., & Shi, G. W. (2010). The efficacy of donepezil for post-stroke aphasia: A pilot case control study. Zhonghua Nei Ke Za Zhi, 49, 115-118.
33. Cherney, L. R., & Small, S. L. (2006). Task-dependent changes in brain activation following therapy for nonfluent aphasia: Discussion of two individual cases. Journal of International Neuropsychological Society, 6, 828-842. (Pubitemid 46415888)
34. Cherney, L. R., Patterson, J. P., Raymer, A., Frymark, T., & Schooling, T. (2008). Evidence-based systematic review: Effects of intensity of treatment and constraint-induced language therapy for individuals with stroke-induced aphasia. Journal of Speech, Language, and Hearing Research, 51, 1282-1299.
35. Cherney, L. R., Erickson, R. K., & Small, S. L. (2010). Epidural cortical stimulation as adjunctive treatment for non-fluent aphasia: Preliminary findings. Journal of Neurology, Neurosurgery, and Psychiatry, 81, 1014-1021.
36. Chuah, Y. M. L., & Chee, M. W. L. (2008). Cholinergic augmentation modulates visual task performance in sleep-deprived young adults. Journal of Neuroscience, 28, 11369-11377.
37. Cicerone, K. D., Langenbahn, D. M., Braden, C., Malec, J. F., Kalmar, K., Fraas, M., et al. (2011). Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Archives of Physical Medicine and Rehabilitation, 92, 519-530.
38. Code, C. (2001). Multifactorial processes in recovery from aphasia: Developing the foundations for a multileveled framework. Brain and Language, 77, 25-44. (Pubitemid 32510139)
39. Code, C., Torney, A., Gildea-Howardine, E., & Willmes, K. (2010). Outcome of a 1-month therapy intensive for chronic aphasia: Variable individual responses. Seminars in Speech and Language, 31, 21-33.
40. Coelho, F., & Birks, J. (2001). Physostigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews, 2, CD001499.
41. Cohen, L., Chaaban, B., & Habert, M.-O. (2004). Transient improvement of aphasia with zolpidem. The New England Journal of Medicine, 350, 949-950.
42. Corbett, F., Jefferies, E., & Lambon Ralph, M. A. (2008). The use of cueing to alleviate recurrent verbal perseverations: Evidence from transcortical sensory aphasia. Aphasiology, 22, 363-382. (Pubitemid 351486592)
43. Cramer, S. C. (2008). Repairing the human brain after stroke. II. Restorative therapies. Annals of Neurology, 63, 549-560.
44. Cramer, S. C., & Riley, J. D. (2008). Neuroplasticity and brain repair after stroke. Current Opinion in Neurology, 21, 76-82.
45. Crinion, J. T., & Leff, A. P. (2007). Recovery and treatment of aphasia after stroke: Functional imaging studies. Current Opinion in Neurology, 20, 667-673. (Pubitemid 350085008)
46. Crosson, B., Moore, A. B., Gopinath, K., White, K. D., Wierenga, C. E., Gaiefsky, M. E., et al. (2005). Role of the right and left hemispheres in recovery of function during treatment of intention in aphasia. Journal of Cognitive Neuroscience, 17, 392-406. (Pubitemid 40364528)
47. Dale, A. M., Fischl, B., & Sereno, M. I. (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuro-Image, 9, 179-194. (Pubitemid 29369874)
48. de Boissezon, X., Peran, P., de Boysson, C., & Démonet, J. F. (2007). Pharmacotherapy of aphasia: Myth or reality? Brain and Language, 102, 114-125. (Pubitemid 46809752)
49. de Riesthal, M., & Wertz, R. T. (2004). Prognosis for aphasia: Relaitonship between selected biographical and behavioural variables and outcome improvement. Aphasiology, 18, 899-915. (Pubitemid 39378257)
50. Dickey, L., Kagan, A., Lindsay, M. P., Fang, J., Rowland, A., & Black, S. (2010). Incidence and profile of inpatient stroke-induced aphasia in Ontario, Canada. Archives of Physical Medicine and Rehabilitation, 91, 196-202.
51. Dobkin, B. H. (2004). Strategies for stroke rehabilitation. Lancet Neurology, 3, 528-536. (Pubitemid 39489836)
52. Elman, R. J., Ogar, J., & Elman, S. H. (2000). Aphasia: Awareness, advocacy, and activism. Aphasiology, 14, 455-459. (Pubitemid 30391865)
53. Endres, M., Engelhardt, B., Koistinaho, J., Lindvall, O., Meairs, S., Mohr, J. P., et al. (2008). Improving outcome after stroke: Overcoming the translational roadblock. Cerebrovascular Diseases, 25, 268-278. (Pubitemid 351450431)
54. Engelter, S. T., Gostynski, M., Papa, S., Frei, M., Born, C., Ajdacic-Gross, V., et al. (2006). Epidemiology of aphasia attributable to first ischemic stroke: Incidence, severity, fluency, etiology, and thrombolysis. Stroke, 37, 1379-1384. (Pubitemid 44305713)
55. Eslinger, P. J., & Damasio, A. R. (1981). Age and type of aphasia in patients with stroke. Journal of Neurology, Neurosurgery, and Psychiatry, 44, 377-381. (Pubitemid 11046270)
56. Ferris, S., Ihl, R., Robert, P., Winblad, B., Gatz, G., Tennigkeit, F., et al. (2009). Treatment effects of memantine on language in moderate to severe Alzheimer's disease patients. Alzheimer's & Dementia, 5, 369-374.
57. Fischl, B., Sereno, M. I., & Dale, A. M. (1999). Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. NeuroImage, 9, 195-207. (Pubitemid 29369875)
58. Fischl, B., Liu, A., & Dale, A. M. (2001). Automated manifold surgery: Constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Transactions on Medical Imaging, 20, 70-80. (Pubitemid 32293421)
59. FitzGerald, D. B., Crucian, G. P., Mielke, J. B., Shenal, B. V., Burks, D., Womack, K. B., et al. (2008). Effects of donepezil on verbal memory after semantic processing in healthy older adults. Cognitive and Behavioral Neurology, 21, 57-64.
60. Floel, A., & Cohen, L. G. (2010). Recovery of function in humans: Cortical stimulation and pharmacological treatments after stroke. Neurobiology of Disease, 37, 243-251.
61. Fridriksson, J., Moser, D., Bonilha, L., Morrow-Odom, K. L., Shaw, H., Fridriksson, A., et al. (2007). Neural correlates of phonological and semantic-based anomia treatment in aphasia. Neuropsychologia, 45, 1812-1822. (Pubitemid 46386112)
62. Fucetola, R., Connor, L. T., Perry, J., Leo, P., Tucker, F. M., & Corbetta, M. (2005a). Aphasia severity, semantics, and depression predict functional communication in acquired aphasia. Aphasiology, 20, 449-461.
63. Fucetola, R., Tucker, F., Blank, K., & Corbetta, M. (2005b). A process for translating evidence-based aphasia treatment into clinical practice. Aphasiology, 19, 411-422. (Pubitemid 40716117)
64. Galletta, E. E., Rao, P. R., & Barrett, A. M. (2011). Transcranial magnetic stimulation (TMS): Potential progress for language improvement in aphasia. Topics in Stroke Rehabilitation, 18, 87-91.
65. Goldstein, L. B. (2009). Amphetamine trials and tribulations. Stroke, 40(3 Suppl), S133-S135.
66. Gonzalez Rothi, L. J., & Barrett, A. M. (2006). The changing view of neurorehabilitation: A new era of optimism. Journal of International Neuropsychological Society, 12, 812-815. (Pubitemid 46415886)
67. Gotts, S. J., della Rocchetta, A. I., & Cipolotti, L. (2002). Mechanisms underlying perseveration in aphasia: Evidence from a single case study. Neuropsychologia, 40, 1930-1947.
68. Greenwood, P. M. (2007). Functional plasticity in cognitive aging: Review and hypothesis. Neuropsychology, 21, 657-673. (Pubitemid 350116507)
69. Grenner, J., Enderby, P., & Whurr, R. (2001). Pharmacological treatment for aphasia following stroke. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000424. doi:10.1002/14651858. CD000424.
70. Grön, G., Kirstein, M., Thielscher, A., Riepe, M. W., & Spitzer, M. (2005). Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology, 182, 170-179. (Pubitemid 41400874)
71. Güngör, L., Terzi, M., & Onar, M. K. (2011). Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases? Brain and Language Jan 10. [Epub ahead of print].
72. Gupta, S. R., & Mlcoch, A. G. (1992). Bromocriptine treatment of nonfluent aphasia. Archives of Physical Medicine and Rehabilitation, 73, 373-376.
73. Gupta, S. R., Mlcoch, A. G., Scolaro, C., & Moritz, T. (1995). Bromocriptine treatment of nonfluent aphasia. Neurology, 45, 2170-2173. (Pubitemid 27100242)
74. Heiss, W. D., & Thiel, A. (2006). A proposed regional hierarchy in recovery of post-stroke aphasia. Brain and Language, 98, 118-123. (Pubitemid 43775696)
75. Hillis, A. E. (2007). Pharmacological, surgical, and neurovascular interventions to augment acute aphasia recovery. American Journal of Physical Medicine & Rehabilitation, 86, 426-434. (Pubitemid 46791497)
76. Holland, A. L., Greenhouse, J. B., Fromm, D., & Swindell, C. S. (1989). Predictors of language restitution following stroke: A multivariate analysis. Journal of Speech and Hearing Research, 32, 232-238. (Pubitemid 19159365)
77. Huber, W. (1999). The role of piracetam in the treatment of acute and chronic aphasia. Pharmacopsychiatry, 32(Suppl 1), 38-43.
78. Hughes, J. D., Jacobs, D. H., & Heilman, K. M. (2000). Neuropharmacology and linguistic neuroplasticity. Brain and Language, 71, 96-101. (Pubitemid 30139643)
79. Hutchison, C. W., Nathan, P. J., Mrazek, L., & Stough, C. (2001). Cholinergic modulation of speed of early information processing: The effect of donepezil on inspection time. Psychopharmacology, 155, 440-442. (Pubitemid 32523116)
80. Jacobs, D. H., Shuren, J., Gold, M., Adair, J. C., Bowers, D., Williamson, D. J. G., et al. (1996). Physostigmine pharmacotherapy for anomia. Neurocase, 2, 83-91. (Pubitemid 26171463)
81. Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002). Improved optimisation for the robust and accurate linear registration and motion correction of brain images. NeuroImage, 17, 825-841. (Pubitemid 35317016)
82. Jianu, D. C., Muresanu, D. F., Bajenaru, O., Popescu, B. O., Deme, S. M., Moessler, H., et al. (2010). Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery. Journal of Medicine and Life, 3, 297-307.
83. Kabasawa, H., Matsubara, M., Kamimoto, K., Hibino, H., Banno, T., & Nagai, H. (1994). Effects of bifemelane hydrochloride on cerebral circulation and metabolism in patients with aphasia. Clinical Therapeutics, 16, 471-482. (Pubitemid 24321680)
84. Kasa, P., Papp, H., Kasa, P., & Torok, I. (2000). Donepezil dosedependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience, 101, 89-100.
85. Kelly, H., Brady, M. C., & Enderby, P. (2010). Speech and language therapy for aphasia following stroke. Cochrane Database of Systematic Reviews, 12(5), CD000425.
86. Kertesz, A. (1979). Aphasia and associated disorders. Taxonomy, localization, and recovery. New York: Grune and Stratton.
87. Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., et al. (2008). Galantamine in frontotemporal dementia and primary progressive aphasia. Dementia and Geriatric Cognitive Disorders, 25, 178-185. (Pubitemid 351196131)
88. Kessler, J., Thiel, A., Karbe, H., & Heiss, W. D. (2000). Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke, 31, 2112-2116.
89. Kirmess, M., & Maher, L. M. (2010). Constraint induced language therapy in early aphasia rehabilitation. Aphasiology, 24, 725-736.
90. Kirvell, S. L., Elliott, M. S., Kalaria, R. N., Hortobágyi, T., Ballard, C., & Francis, P. T. (2010). Vesicular glutamate transporter and cognition in stroke. A case-control autopsy study. Neurology, 75, 1803-1809.
91. Klein, R. B., & Albert, M. L. (2004). Can drug therapies improve language functions of individuals with aphasia? A review of the evidence. Seminars in Speech and Language, 25(2), 193-204. (Pubitemid 38702062)
92. Knecht, S., Breitenstein, C., Bushuven, S., Wailke, S., Kamping, S., Flöel, A., et al. (2004). Levodopa: Faster and better word learning in normal humans. Annals of Neurology, 56, 20-26. (Pubitemid 38857356)
93. Kulisevsky, J., García-Sánchez, C., Berthier, M. L., Barbanoj, M., Pascual-Sedano, B., Gironell, A., et al. (2000). Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A 2-year follow-up study of previously untreated patients. Movement Disorders, 15, 613-626. (Pubitemid 30479613)
94. Lambon Ralph, M. A., Snell, C., Fillingham, J. K., Conroy, P., & Sage, K. (2010). Predicting the outcome of anomia therapy for people with aphasia post CVA: Both language and cognitive status are key predictors. Neuropsychological Rehabilitation, 20, 289-305.
95. Laska, A. C., Hellblom, A., Murray, V., Kahan, T., & Von Arbin, M. (2001). Aphasia in acute stroke and relation to outcome. Journal of Internal Medicine, 249, 413-422. (Pubitemid 34208945)
96. Law, J., Rush, R., Pringle, A.-M., Irving, A.-M., Huby, G., Smith, M., et al. (2009). The incidence of cases of aphasia following first stroke referred to speech and language therapy services in Scotland. Aphasiology, 23, 1266-1275.
97. Lazar, R. M., & Antoniello, D. (2008). Variability in recovery from aphasia. Current Neurology and Neuroscience Reports, 8, 497-502.
98. Lazar, R. M., Speizer, A. E., Festa, J. R., Krakauer, J. W., & Marshall, R. S. (2008). Variability in language recovery after first-time stroke. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 530-534. (Pubitemid 351571870)
99. Lazar, R. M., Minzer, B., Antoniello, D., Festa, J. R., Krakauer, J. W., & Marshall, R. S. (2010). Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke, 41, 1485-1488.
100. Lee, A. W., & Hillis, A. E. (2008). The pharmacological treatment of aphasia. In B. Stemmer & H. A. Whitaker (Eds.), Handbook of the neuroscience of language (pp. 407-415). London: Academic.
101. Leemann, B., Laganaro, M., Chetelat-Mabillard, D., & Schnider, A. (2010). Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo. Neurorehabilitation and Neural Repair. doi:10.1177/1545968310376938.
102. Li, S. C., Lindenberger, U., & Sikström, S. (2001). Aging cognition: From neuromodulation to representation. Trends in Cognitive Sciences, 5, 479-486. (Pubitemid 33000519)
103. Liepert, J. (2008). Pharmacotherapy in restorative neurology. Current Opinion in Neurology, 21, 639-643.
104. Linebarger, M., McCall, D., Virata, T., & Berndt, R. S. (2007). Widening the temporal window: Processing support in the treatment of aphasic language production. Brain and Language, 100, 53-68. (Pubitemid 44751114)
105. Lipton, S. A. (2007). Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation. Current Drug Targets, 8, 621-632. (Pubitemid 46785060)
106. Luria, A., Naydyn, V. L., Tsvetkova, L. S., & Vinarskaya, E. N. (1969). Restoration of higher cortical function following local brain damage. In P. J. Vinken & G. W. Bruyn (Eds.), Handbook of clinical neurology (pp. 368-433). Amsterdam: North-Holland Publishing Company.
107. Mackowiak-Cordoliani, M. A., Bombois, S., Memin, A., Hénon, H., & Pasquier, F. (2005). Poststroke dementia in the elderly. Drugs & Aging, 22, 483-493. (Pubitemid 41003062)
108. Malykh, A. G., & Sadaie, M. R. (2010). Piracetam and piracetam-like drugs. From basic science to novel clinical applications to CNS disorders. Drugs, 70, 287-312.
109. Martin, H. G., & Wang, Y. T. (2010). Blocking the deadly effects of the NMDA receptor in stroke. Cell, 140, 174-176.
110. Martinsson, L., & Eksborg, S. (2004). Drugs for stroke recovery: The example of amphetamines. Drugs & Aging, 21, 67-79. (Pubitemid 38293787)
111. McClung, J. S., Rothi, L. J., & Nadeau, S. E. (2010). Ambient experience in restitutive treatment of aphasia. Frontiers in Human Neuroscience, 4, 183.
112. McKeage, K. (2009). Memantine: A review of its use in moderate to severe Alzheimer's disease. CNS Drugs, 23, 881-897.
113. McNamara, P., & Albert, M. L. (2004). Neuropharmacology of verbal perseveration. Seminars in Speech and Language, 25, 309-321. (Pubitemid 40012093)
114. McNeil, M. R., Doyle, P. J., Spencer, K. A., Goda, A. J., Flores, D., & Small, S. L. (1997). A double-blind, placebo-controlled study of pharmacological and behavioural treatment of lexical-semantic deficits in aphasia. Aphasiology, 11, 385-400. (Pubitemid 27183153)
115. Meinzer, M., Djundja, D., Barthel, G., Elbert, T., & Rockstroh, B. (2005). Long-term stability of improved language functions in chronic aphasia after constraint-induced aphasia therapy. Stroke, 36, 1462-1466. (Pubitemid 40967513)
116. Meinzer, M., Streiftau, S., & Rockstroh, B. (2007). Intensive language training in the rehabilitation of chronic aphasia: Efficient training by laypersons. Journal of International Neuropsychological Society, 13, 846-853. (Pubitemid 47299454)
117. Meinzer, M., Flaisch, T., Breitenstein, C., Wienbruch, C., Elbert, T., & Rockstroh, B. (2008). Functional re-recruitment of dysfunctional brain areas predicts language recovery in chronic aphasia. NeuroImage, 39, 2038-2046.
118. Meinzer, M., Harnish, S., Conway, T., & Crosson, B. (2011). Recent developments in functional and structural imaging of aphasia recovery after stroke. Aphasiology, 25, 271-290.
119. Menke, R., Meinzer, M., Kugel, H., Deppe, M., Baumgärtner, A., Schiffbauer, H., et al. (2009). Imaging short-and long-term training success in chronic aphasia. BMC Neuroscience, 10, 118.
120. Mesulam, M., Siddique, T., & Cohen, B. (2003). Cholinergic denervation in a pure multi-infarct state: Observations on CADASIL. Neurology, 60, 1183-1185. (Pubitemid 36418785)
121. Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., et al. (2006). NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature, 439, 988-992. (Pubitemid 43292418)
122. Naeser, M. A., Martin, P I., Lundgren, K., Klein, R., Kaplan, J., Treglia, E., et al. (2010). Improved language in a chronic nonfluent aphasia patient after treatment with CPAP and TMS. Cognitive and Behavioral Neurology, 23, 29-38.
123. Nakahata, K, Kinoshita, H., Hama-Tomioka, K, Ishida, Y, Matsuda, N., Hatakeyama, N, et al. (2008). Cholinesterase inhibitor donepezil dilates cerebral parenchymal arterioles via the activation of neuronal nitric oxide synthase. Anesthesiology, 109, 124-129.
124. Nicholas, M., Connor, L. T, Obler, L. K, & Albert, M. L. (1998). Aging, language, and language disorders. In M. T. Sarno (Ed.), Acquired Aphasia (3rd ed., pp. 413-449). San Diego: Academic.
125. Olesen, J., Baker, M. G., Freund, T, di Luca, M., Mendlewicz, J., Ragan, I., et al. (2006). Consensus documents on European brain research. Journal of Neurology, Neurosurgery, and Psychiatry, 77(Suppl I), i1-i49. (Pubitemid 44174444)
126. Orgogozo, J. M., Rigaud, A. S., Stöffler, A., Möbius, H. J., & Forette, F. (2002). Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebocontrolled trial (MMM 300). Stroke, 33, 1834-1839. (Pubitemid 34761071)
127. Ozeren, A., Sarica, Y, Mavi, H., & Demirkiran, M. (1995). Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia. Acta Neurologica Belgica, 95, 235-238. (Pubitemid 26020789)
128. Parsons, C. G., Stöffler, A., & Danysz, W (2007). Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology, 53, 699-723. (Pubitemid 47532143)
129. Parton, A., Coulthard, E., & Husain, M. (2005). Neuropharmacological modulation of cognitive deficits after brain damage. Current Opinion in Neurology, 18, 675-680. (Pubitemid 41669141)
130. Pashek, G. V, & Bachman, D. L. (2003). Cognitive, linguistic, and motor speech of donepezil hydrochloride in a patient with stroke-related aphasia and apraxia of speech. Brain and Language, 87, 179-180.
131. Pedersen, P M., Jørgensen, H. S., Nakayama, H., Raaschou, H. O., & Olsen, T. S. (1995). Aphasia in acute stroke: Incidence, determinants, and recovery. Annals of Neurology, 38, 659-666.
132. Pedersen, P M., Vinter, K, & Olsen, T. S. (2004). Aphasia after stroke: Type, severity and prognosis. The Copenhagen aphasia study. Cerebrovascular Diseases, 17, 35-43. (Pubitemid 38145906)
133. Peisker, T, Bartoš, A., Skoda, O., Ibrahim, I., & Kalvach, P (2010). Impact of aging on cerebral vasoregulation and parenchymal integrity. Journal of Neurological Sciences, 299, 112-115.
134. Price, J. L., McKeel, D. W Jr., Buckles, V D., Roe, C. M., Xiong, C, Grundman, M., et al. (2009). Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging, 30, 1026-1036.
135. Price, C. J., Seghier, M. L., & Leff, A. P (2010). Predicting language outcome and recovery after stroke: The PLORAS system. Nature Reviews. Neurology, 6, 202-210.
136. Pulvermüller, F., & Berthier, M. L. (2008). Aphasia therapy on a neuroscience basis. Aphasiology, 22, 563-599. (Pubitemid 351891162)
137. Pulvermüller, F., Neininger, B., Elbert, T, Mohr, B., Rockstroh, B., Koebbel, P, et al. (2001). Constraint-induced therapy of chronic aphasia following stroke. Stroke, 32, 1621-1626. (Pubitemid 32631914)
138. Pulvermüller, F., Hauk, O., Zohsel, K, Neininger, B., & Mohr, B. (2005). Therapy-related reorganization of language in both hemispheres of patients with chronic aphasia. NeuroImage, 28, 481-489. (Pubitemid 41443517)
139. Raymer, A. M. (2003). Treatment of adynamia in aphasia. Front Bioscience, 8, s845-s851. (Pubitemid 39140202)
140. Raymer, A. M., Bandy, D., & Adair, J. C. (2001). Effects of bromocriptine in a patient with crossed nonfluent aphasia: A case report. Archives of Physical Medicine and Rehabilitation, 82, 139-144. (Pubitemid 32057633)
141. Román, G C, & Kalaria, R. N. (2006). Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiology of Aging, 27, 1769-1785. (Pubitemid 44572575)
142. Román, G C, Wilkinson, D. G, Doody, R. S., Black, S. E., Salloway, S. P, & Schindler, R. J. (2005). Donepezil in vascular dementia: Combined analysis of two large-scale clinical trials. Dementia and Geriatric Cognitive Disorders, 20, 338-344. (Pubitemid 41642791)
143. Sabe, L., Leiguarda, R., & Starkstein, S. E. (1992). An open-label trial of bromocriptine in nonfluent aphasia. Neurology, 42, 1637-1638.
144. Sabe, L., Salvarezza, F., García Cuerva, A., Leiguarda, R., & Starkstein, S. (1995). A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology, 45, 2272-2274. (Pubitemid 27100261)
145. Sarter, M., Hasselmo, M. E., Bruno, J. P, & Givens, B. (2005). Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection. Brain Research Reviews, 48, 98-111. (Pubitemid 40215784)
146. Saur, D., Lange, R., Baumgaertner, A., Schraknepper, V, Willmes, K, Rijntjes, M., et al. (2006). Dynamics of language reorganization after stroke. Brain, 129, 1371-1384. (Pubitemid 43999371)
147. Sawyer, E., Mauro, L. S., & Ohlinger, M. J. (2008). Amantadine enhancement of arousal and cognition after traumatic brain injury. The Annals of Pharmacotherapy, 42, 247-252. (Pubitemid 351238573)
148. Schlaug, G, Marchina, S., & Norton, A. (2009). Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy. Annals of New York Academy of Sciences, 1169, 385-394.
149. Selden, N. R., Gitelman, D. R., Salamon-Murayama, N., et al. (1998). Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain, 121, 2249-2257. (Pubitemid 28552464)
150. Seniów, J., Litwin, M., Litwin, T, Lesniak, M., & Czlonkowska, A. (2009). New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. Journal of Neurological Sciences, 28, 214-218.
151. Sharp, S. I., Francis, P T, Elliott, M. S., Kalaria, R. N, Bajic, N, Hortobagyi, T, et al. (2009). Choline acetyltransferase activity in vascular dementia and stroke. Dementia and Geriatric Cognitive Disorders, 28, 233-238.
152. Shisler, R. J., Baylis, G C, & Frank, E. M. (2000). Pharmacological approaches to the treatment and prevention of aphasia. Aphasiology, 14, 1163-1186. (Pubitemid 32051344)
153. Šimic, G, Mrzljak, L., Fucic, A., et al. (1999). Nucleus subputaminalis (Ayala): The still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area. Neuroscience, 89, 73-89. (Pubitemid 29049028)
154. Simmons-Mackie, N, Code, C, Armstrong, E., Stiegler, L., & Elman, R. J. (2002). What is aphasia? Results of an international survey. Aphasiology, 16, 837-848.
155. Small, S. L., & Llano, D. A. (2009). Biological approaches to aphasia treatment. Current Neurology and Neuroscience Reports, 9, 443-450.
156. Smith, S. M. (2002). Fast robust automated brain extraction. Human Brain Mapping, 17, 143-155. (Pubitemid 35253488)
157. Staekenborg, S. S., van der Flier, W. M., van Straaten, E. C, Lane, R., Barkhof, F., & Scheltens, P (2008). Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke, 39, 317-322. (Pubitemid 351619449)
158. Starkstein, S. E., & Robinson, R. G (1988). Depression and aphasia. Aphasiology, 2, 1-20.
159. Stys, P K, & Lipton, S. A. (2007). White matter NMDA receptors: An unexpected new therapeutic target? Trends in Pharmacological Sciences, 28, 561-566. (Pubitemid 350030933)
160. Swartz, R. H., Sahlas, D. J., & Black, S. E. (2003). Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? Journal of Stroke and Cerebrovascular Diseases, 12, 29-36. (Pubitemid 36292855)
161. Tanaka, Y., & Bachman, D. L. (2007). Pharmacotherapy of aphasia. In L. S. Connor & L. K. Obler (Eds.), Neurobehavior of language and cognition studies of normal aging and brain damage (pp. 159-162). Berlin: SpringerLink.
162. Tanaka, Y., Miyazaki, M., & Albert, M. L. (1997). Effect of increased cholinergic activity on naming in aphasia. Lancet, 350, 116-117.
163. Triggle, D. J. (1996). Dictionary of pharmacological agents. Boca Raton: Chapman & Hall/CRC.
164. Tsikunov, S. G., & Belokoskova, S. G. (2007). Psychophysiological analysis of the influence of vasopressin on speech in patients with poststroke aphasias. Spanish Journal of Psychology, 10, 178-188.
165. Tsouli, S., Kyritsis, A. P., Tsagalis, G., Virvidaki, E., & Vemmos, K. N. (2009). Significance of aphasia after first-ever acute stroke: Impact on early and late outcomes. Neuroepidemiology, 33, 96-102.
166. Tsz-Ming, C., & Kaufer, D. J. (2001). Effects of donepezil on aphasia, agnosia, and apraxia in patients with cerebrovascular lesions. The Journal of Neuropsychiatry and Clinical Neurosciences, 13, 140. abstract.
167. Uchida, S., Suzuki, A., Kagitani, F., & Hotta, H. (2000). Effects of age on cholinergic vasodilation of cortical cerebral blood vessels in rats. Neuroscience Letters, 294, 109-112.
168. van Dyck, C., Schmitt, F. A., Olin, J. T., & for the Memantine MEM-MD-02 Study Group. (2006). A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. The American Journal of Geriatric Psychiatry, 14, 428-437.
169. van Wageningen, H., Jørgensen, H. A., Specht, K., Eichele, T., & Hugdahl, K. (2009). The effects of the glutamate antagonist memantine on brain activation to an auditory perception task. Human Brain Mapping, 30, 3616-3624.
170. Walker-Batson, D., Unwin, H., Curtis, S., Allen, E., Wood, M., Smith, P., et al. (1992). Use of amphetamine in the treatment of aphasia. Restorative Neurology and Neuroscience, 4, 47-50.
171. Walker-Batson, D., Curtis, S., Natarajan, R., Ford, J., Dronkers, N., Salmeron, E., et al. (2001). Double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke, 32, 2093-2098.
172. Whiting, E., Chenery, H. J., Chalk, J., & Copland, D. A. (2008). Dexamphetamine boosts naming treatment effects in chronic aphasia. Journal of International Neuropsychological Society, 13, 972-979.
173. Wierenga, C. E., Benjamin, M., Gopinath, K., Perlstein, W. M., Leonard, C. M., Rothi, L. J., et al. (2008). Age-related changes in word retrieval: Role of bilateral frontal and subcortical networks. Neurobiology of Aging, 29, 436-451. (Pubitemid 351215585)
174. Wilcock, G., Möbius, H. J., Stöffler, A., & MMM 500 group. (2002). A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). International Clinical Psychopharmacology, 17, 297-305. (Pubitemid 35283717)
175. Wilkinson, D., & Andersen, H. F. (2007). Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 24, 138-145. (Pubitemid 47094073)
176. Wilkinson, D., Róman, G., Salloway, S., Hecker, J., Boundy, K., Kumar, D., et al. (2010). The long-term efficacy and tolerability of donepezil in patients with vascular dementia. International Journal of Geriatric Psychiatry, 25, 305-313.
177. Winblad, B. (2005). Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Reviews, 11, 169-182. (Pubitemid 41278980)
178. Worsley, K. J. (2001). Statistical analysis of activation images. In P. Jezzard, P. M. Matthews, S. M. Smith (Eds.), Functional MRI: An introduction to methods. Ch14, OUP.
179. Yesavage, J. A., Mumenthaler, M. S., Taylor, J. L., Friedman, L., O'Hara, R., Sheikh, J., et al. (2002). Donepezil and flight simulator performance: Effects on retention of complex skills. Neurology, 59, 123-125. (Pubitemid 34742807)
180. Ziganshina, L. E., Abakumova, T., & Kuchaeva, A. (2010). Cerebrolysin for acute ischaemic stroke. Cochrane Database of Systematic Reviews, 14(4), CD007026.